Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores
Services
Services
Date issued
2015Journal title
Allergy
Type of content
Publicación de congreso
